These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 9761305

  • 21. Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
    Crino PB.
    J Child Neurol; 2004 Sep; 19(9):716-25. PubMed ID: 15563019
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Aspects of tuberous sclerosis complex (TSC) protein function in the brain.
    Ramesh V.
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):579-83. PubMed ID: 12773159
    [Abstract] [Full Text] [Related]

  • 25. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, Kotulska K, Kwiatkowski DJ.
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Molecular genetic advances in tuberous sclerosis.
    Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ.
    Hum Genet; 2000 Aug; 107(2):97-114. PubMed ID: 11030407
    [Abstract] [Full Text] [Related]

  • 29. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
    Jiang WG, Sampson J, Martin TA, Lee-Jones L, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE.
    Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
    [Abstract] [Full Text] [Related]

  • 30. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M, Verhaaf B, Goedbloed MA, Reuser AJ, van den Ouweland AM, Halley DJ.
    Hum Mol Genet; 2001 Dec 01; 10(25):2889-98. PubMed ID: 11741832
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.
    Nellist M, Goedbloed MA, Halley DJ.
    Biochem Soc Trans; 2003 Jun 01; 31(Pt 3):587-91. PubMed ID: 12773161
    [Abstract] [Full Text] [Related]

  • 35. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology.
    Crino PB, Trojanowski JQ, Dichter MA, Eberwine J.
    Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):14152-7. PubMed ID: 8943076
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tuberous sclerosis: between genetic and physical analysis.
    Halley DJ.
    Acta Genet Med Gemellol (Roma); 1996 Nov 26; 45(1-2):63-75. PubMed ID: 8872012
    [Abstract] [Full Text] [Related]

  • 38. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR.
    Biochem Soc Trans; 2003 Jun 26; 31(Pt 3):592-6. PubMed ID: 12773162
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The tuberous sclerosis complex genes in tumor development.
    Mak BC, Yeung RS.
    Cancer Invest; 2004 Jun 26; 22(4):588-603. PubMed ID: 15565817
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.